SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-11-069426
Filing Date
2011-12-12
Accepted
2011-12-12 16:33:26
Documents
5
Period of Report
2011-12-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v242855_8k.htm 8-K 34978
2 EXHIBIT 10.1 v242855_ex10-1.htm EX-10.1 56299
3 EXHIBIT 10.2 v242855_ex10-2.htm EX-10.2 60236
4 EXHIBIT 10.3 v242855_ex10-3.htm EX-10.3 48061
5 EXHIBIT 99.1 v242855_ex99-1.htm EX-99.1 20524
  Complete submission text file 0001144204-11-069426.txt   221458
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13441 | Film No.: 111256461
SIC: 2836 Biological Products, (No Diagnostic Substances)